About Sydenham Laboratories
Sydenham Laboratories is a Healthcare company based in Dasmarinas (Philippines) founded in 1971, and was acquired by Philab in December 2017. Pharmaceutical drugs are manufactured by Sydenham Laboratories in the Philippines. Its focus areas include Traditional Pharmaceuticals.
Company details
Sydenham Laboratories was established in 1971 as a pharmaceutical manufacturer based in Dasmarinas, Philippines. Operations focus on the production of various drugs within the healthcare sector. The company maintains its online presence through the domain sydenhamlab.com. Activities are centered on drug formulation and distribution, serving regional markets from its Philippine location. Standard industry practices are followed in all manufacturing processes.
- Headquarters Dasmarinas, Philippines
- Stage Acquired
- SectorsHealthcare
- Website sydenhamlab.com
- Acquired by Philab (Dec 2017)
Investors in Sydenham Laboratories
Sydenham Laboratories has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Philab.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Life science equipment and diagnostic services are provided. | 1959 | philab.com | Taguig, Philippines |
Investor details for Sydenham Laboratories
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Sydenham Laboratories
11 people are tracked at Sydenham Laboratories (2 in leadership, 9 in team).
| Name | Role | Group |
|---|---|---|
Roberto Bautista | General Manager & COO | Leadership |
Jacob Pena | CEO | Leadership |
Demae Egalla | Digital Marketing Officer | Team |
Ana Ria Nannette Nueva | Account Executive | Team |
Patrick Morales | Technical Specialist | Team |
Elaine Sabroso | Talent Development Specialist | Team |
Jamaica Paulino | Training Section Manager | Team |
Kenneth Andes | Marketing & Corporate Communications Assistant Manager | Team |
Paula Aguirre | Recruitment Specialist | Team |
Sydenham Laboratories (SLI) | Marketing And Corporate Communications | Team |
Maria Christina Rosema | Recruitment Specialist | Team |
Complete people profiles for Sydenham Laboratories
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Sydenham Laboratories
2 dated milestones of Sydenham Laboratories across 46 years, from founding to its latest funding, stage changes and deals.
- Founded Sydenham Laboratories is founded.
- Exit Acquired by Philab.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sydenham Laboratories
Sydenham Laboratories was founded in 1971.
Sydenham Laboratories is headquartered in Dasmarinas, Philippines. It is registered at Dasmarinas, Cavite, Philippines.
Sydenham Laboratories was established in 1971 as a pharmaceutical manufacturer based in Dasmarinas, Philippines. Operations focus on the production of various drugs within the healthcare sector. The company maintains its online presence through the domain sydenhamlab.com. Activities are centered on drug formulation and distribution, serving regional markets from its Philippine location. Standard industry practices are followed in all manufacturing processes.
Sydenham Laboratories has 1 investor. Key investors include Philab.
Yes. Sydenham Laboratories was acquired by Philab in December 2017.